Loading…

Exenatide reduces oxidative stress and cell death in testis in iron overload rat model

Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron ove...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine 2018-12, Vol.16 (6), p.4349-4356
Main Authors: Yesil, Suleyman, Sungu, Nuran, Kilicarslan, Aydan, Kuskonmaz, Serife Mehlika, Kara, Halil, Kucuk, Aysegul, Polat, Fazli, Kavutcu, Mustafa, Arslan, Mustafa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923
cites cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923
container_end_page 4356
container_issue 6
container_start_page 4349
container_title Experimental and therapeutic medicine
container_volume 16
creator Yesil, Suleyman
Sungu, Nuran
Kilicarslan, Aydan
Kuskonmaz, Serife Mehlika
Kara, Halil
Kucuk, Aysegul
Polat, Fazli
Kavutcu, Mustafa
Arslan, Mustafa
description Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.
doi_str_mv 10.3892/etm.2018.6795
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6256837</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A565735368</galeid><sourcerecordid>A565735368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</originalsourceid><addsrcrecordid>eNptks9vFSEQx4nR2ObZo1dD4sXLPvmxsHAxaZpaTZp4Ua-EhaGl2YUK-17a_142fa3WCAcmw2e-ky8MQm8p2XKl2UdY5i0jVG3loMULdEwHzTpKqHh5iIlW9Aid1HpD2hKSKiVeoyNORC-5Jsfo5_kdJLtED7iA3zmoON9F3zJ7wHUpUCu2yWMH04Q92OUax4QXqEusaxRLTjjvoUzZelzsgufsYXqDXgU7VTg5nBv04_P597Mv3eW3i69np5ed6xVbOsqHoLhikgqvNeOW9CEE5wTrnXWMKu8lh17zcQRPKLAxcDkG56UImrWCDfr0oHu7G2fwDtJS7GRuS5xtuTfZRvP8JsVrc5X3RjIhFR-awIeDQMm_ds2WmWNdzdoEeVcNo2KQQuueNvT9P-hN3pXU7DWq15L1DfxDXdkJTEwht75uFTWnQoqBC94ab9D2P1TbHubocoIQW_5ZQfdQ4EqutUB48kiJWWfBtFkw6yyYdRYa_-7vh3miH3-e_wa7Ua8D</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2149624659</pqid></control><display><type>article</type><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><source>Open Access: PubMed Central</source><creator>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</creator><creatorcontrib>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</creatorcontrib><description>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2018.6795</identifier><identifier>PMID: 30546390</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Apoptosis ; Biochemistry ; Cell death ; Clinical trials ; Control ; Dextrans ; Dosage and administration ; Endothelium ; Enzymes ; Exenatide ; Ferritin ; Glucagon ; Health aspects ; Hypoglycemic agents ; Immunohistochemistry ; Insulin ; Iron ; Iron (Nutrient) ; Laboratory animals ; Laboratory rats ; Medical research ; Oxidative stress ; Peptides ; Polysaccharides ; Rodents ; Studies ; Superoxides ; Testis ; Type 2 diabetes</subject><ispartof>Experimental and therapeutic medicine, 2018-12, Vol.16 (6), p.4349-4356</ispartof><rights>COPYRIGHT 2018 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright: © Yesil et al. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</citedby><cites>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256837/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256837/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30546390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yesil, Suleyman</creatorcontrib><creatorcontrib>Sungu, Nuran</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kuskonmaz, Serife Mehlika</creatorcontrib><creatorcontrib>Kara, Halil</creatorcontrib><creatorcontrib>Kucuk, Aysegul</creatorcontrib><creatorcontrib>Polat, Fazli</creatorcontrib><creatorcontrib>Kavutcu, Mustafa</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Cell death</subject><subject>Clinical trials</subject><subject>Control</subject><subject>Dextrans</subject><subject>Dosage and administration</subject><subject>Endothelium</subject><subject>Enzymes</subject><subject>Exenatide</subject><subject>Ferritin</subject><subject>Glucagon</subject><subject>Health aspects</subject><subject>Hypoglycemic agents</subject><subject>Immunohistochemistry</subject><subject>Insulin</subject><subject>Iron</subject><subject>Iron (Nutrient)</subject><subject>Laboratory animals</subject><subject>Laboratory rats</subject><subject>Medical research</subject><subject>Oxidative stress</subject><subject>Peptides</subject><subject>Polysaccharides</subject><subject>Rodents</subject><subject>Studies</subject><subject>Superoxides</subject><subject>Testis</subject><subject>Type 2 diabetes</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptks9vFSEQx4nR2ObZo1dD4sXLPvmxsHAxaZpaTZp4Ua-EhaGl2YUK-17a_142fa3WCAcmw2e-ky8MQm8p2XKl2UdY5i0jVG3loMULdEwHzTpKqHh5iIlW9Aid1HpD2hKSKiVeoyNORC-5Jsfo5_kdJLtED7iA3zmoON9F3zJ7wHUpUCu2yWMH04Q92OUax4QXqEusaxRLTjjvoUzZelzsgufsYXqDXgU7VTg5nBv04_P597Mv3eW3i69np5ed6xVbOsqHoLhikgqvNeOW9CEE5wTrnXWMKu8lh17zcQRPKLAxcDkG56UImrWCDfr0oHu7G2fwDtJS7GRuS5xtuTfZRvP8JsVrc5X3RjIhFR-awIeDQMm_ds2WmWNdzdoEeVcNo2KQQuueNvT9P-hN3pXU7DWq15L1DfxDXdkJTEwht75uFTWnQoqBC94ab9D2P1TbHubocoIQW_5ZQfdQ4EqutUB48kiJWWfBtFkw6yyYdRYa_-7vh3miH3-e_wa7Ua8D</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Yesil, Suleyman</creator><creator>Sungu, Nuran</creator><creator>Kilicarslan, Aydan</creator><creator>Kuskonmaz, Serife Mehlika</creator><creator>Kara, Halil</creator><creator>Kucuk, Aysegul</creator><creator>Polat, Fazli</creator><creator>Kavutcu, Mustafa</creator><creator>Arslan, Mustafa</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181201</creationdate><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><author>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Cell death</topic><topic>Clinical trials</topic><topic>Control</topic><topic>Dextrans</topic><topic>Dosage and administration</topic><topic>Endothelium</topic><topic>Enzymes</topic><topic>Exenatide</topic><topic>Ferritin</topic><topic>Glucagon</topic><topic>Health aspects</topic><topic>Hypoglycemic agents</topic><topic>Immunohistochemistry</topic><topic>Insulin</topic><topic>Iron</topic><topic>Iron (Nutrient)</topic><topic>Laboratory animals</topic><topic>Laboratory rats</topic><topic>Medical research</topic><topic>Oxidative stress</topic><topic>Peptides</topic><topic>Polysaccharides</topic><topic>Rodents</topic><topic>Studies</topic><topic>Superoxides</topic><topic>Testis</topic><topic>Type 2 diabetes</topic><toplevel>online_resources</toplevel><creatorcontrib>Yesil, Suleyman</creatorcontrib><creatorcontrib>Sungu, Nuran</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kuskonmaz, Serife Mehlika</creatorcontrib><creatorcontrib>Kara, Halil</creatorcontrib><creatorcontrib>Kucuk, Aysegul</creatorcontrib><creatorcontrib>Polat, Fazli</creatorcontrib><creatorcontrib>Kavutcu, Mustafa</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Source (ProQuest)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yesil, Suleyman</au><au>Sungu, Nuran</au><au>Kilicarslan, Aydan</au><au>Kuskonmaz, Serife Mehlika</au><au>Kara, Halil</au><au>Kucuk, Aysegul</au><au>Polat, Fazli</au><au>Kavutcu, Mustafa</au><au>Arslan, Mustafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>16</volume><issue>6</issue><spage>4349</spage><epage>4356</epage><pages>4349-4356</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>30546390</pmid><doi>10.3892/etm.2018.6795</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2018-12, Vol.16 (6), p.4349-4356
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6256837
source Open Access: PubMed Central
subjects Apoptosis
Biochemistry
Cell death
Clinical trials
Control
Dextrans
Dosage and administration
Endothelium
Enzymes
Exenatide
Ferritin
Glucagon
Health aspects
Hypoglycemic agents
Immunohistochemistry
Insulin
Iron
Iron (Nutrient)
Laboratory animals
Laboratory rats
Medical research
Oxidative stress
Peptides
Polysaccharides
Rodents
Studies
Superoxides
Testis
Type 2 diabetes
title Exenatide reduces oxidative stress and cell death in testis in iron overload rat model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A13%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exenatide%20reduces%20oxidative%20stress%20and%20cell%20death%20in%20testis%20in%20iron%20overload%20rat%20model&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Yesil,%20Suleyman&rft.date=2018-12-01&rft.volume=16&rft.issue=6&rft.spage=4349&rft.epage=4356&rft.pages=4349-4356&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2018.6795&rft_dat=%3Cgale_pubme%3EA565735368%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2149624659&rft_id=info:pmid/30546390&rft_galeid=A565735368&rfr_iscdi=true